Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
1.62
Nov 06 • 3:59 PM ET Dollar change-0.11 Percentage change(-6.36%)
Aftermarket Close
1.72
Aftermarket • 7:40 PM ET Dollar change+0.10 Percentage change(6.17%)
Nov 05, 4:53 PMAemetis returns to Q3 profitability as 45Z tax credits, RNG and ethanol tailwinds drive 49% revenue growth to $88.2M
Index
RUT
Market Cap
118.42M
Enterprise Value
680.67M
Income
-31.20M
Sales
259.13M
Book/sh
-4.30
Cash/sh
0.05
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
220
IPO
Jun 27, 2006
P/E
-
Forward P/E
-
PEG
-
P/S
0.46
P/B
-
P/C
35.24
P/FCF
-
EV/EBITDA
23.82
EV/Sales
2.63
Quick Ratio
0.04
Current Ratio
0.07
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
-0.56
EPS next Y
-0.45
EPS next Q
-0.20
EPS this Y
37.98%
EPS next Y
43.48%
EPS next 5Y
-
EPS past 3/5Y
25.59% 5.95%
Sales past 3/5Y
-6.75% 4.67%
EPS Y/Y TTM
70.86%
Sales Y/Y TTM
28.72%
EPS Q/Q
93.59%
Sales Q/Q
48.93%
Insider Own
6.94%
Insider Trans
-0.20%
Inst Own
25.17%
Inst Trans
9.00%
ROA
-11.28%
ROE
-
ROIC
-
Gross Margin
20.63%
Oper. Margin
6.87%
Profit Margin
-12.04%
SMA20
18.62%
SMA50
-2.54%
SMA200
-17.56%
Trades
Shs Outstand
73.10M
Shs Float
68.03M
52W High
3.80 -57.37%
52W Low
1.11 45.95%
Volatility
15.62% 9.49%
ATR (14)
0.17
RSI (14)
56.92
Beta
1.72
Rel Volume
3.10
Avg Volume
1.03M
Volume
3,206,285
Perf Week
29.60%
Perf Month
-6.36%
Perf Quarter
-2.41%
Perf Half Y
-37.45%
Perf YTD
16.55%
Perf Year
-7.95%
Perf 3Y
-66.67%
Perf 5Y
-92.72%
Perf 10Y
-1.22%
Prev Close
1.73
Price
1.62
Change %
-6.36%
Consensus
Buy
Avg. Price Target
$13.12
Implied Upside
+709.9%
Analysts7incl. previous ratings
Rating Distribution4 Buy · 2 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 16, 2023Upgrade
UBS logoUUBS
Neutral → Buy$2.50 → $10.50+548.1%
Feb 28, 2023Initiated
PPiper Sandler
Underweight$3+85.2%
Dec 14, 2022Initiated
UBS logoUUBS
Neutral$4.25+162.3%
Aug 09, 2022Downgrade
TFC logoTTruist
Buy → Hold$12+640.7%
Nov 22, 2021Resumed
CCredit Suisse
Outperform$31 → $35+2,060.5%
Jul 15, 2021Initiated
EVR logoEEvercore ISI
Outperform$25+1,443.2%
Mar 22, 2021Initiated
CCredit Suisse
Outperform$35+2,060.5%
Mar 19, 2021Initiated
TFC logoTTruist
Buy$35+2,060.5%
Mar 09, 2021Initiated
SF logoSStifel
Buy$25+1,443.2%
Jul 25, 2016Initiated
FFBR Capital
Mkt Perform$2.50+54.3%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Simon Timothy AlanDirectorJun 10 '26Sale2.0510,00020,50042,632Jun 11 12:21 PM
Simon Timothy AlanDirectorJun 10 '26Proposed Sale2.0510,00020,500Jun 10 03:28 PM
Aemetis, Inc. is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. It operates through the North America and India geographical segments. The North America segment manages Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, California, the Goodland Plant, Kansas and the research and development facility in Minnesota. The India segment refers to the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2006 and is headquartered in Cupertino, CA.
Co-FounderMr. Eric A. McAfee
Executive VP & CFOMr. Todd A. Waltz CPA
Executive VP of North America & COOMr. Andrew B. Foster
Executive VPMr. J. Michael Rockett
Executive Vice President of Aemetis InternationalMr. Sanjeev Gupta